IFN-γ exposure in the tumor microenvironment enhances liver cancer stem cell stemness and sorafenib resistance by promoting mitochondrial PD-L1-mediated glycolytic reprogramming and ferroptosis inhibition via the Drp1-GPX4 pathway. This evidence concerns the gene GPX4 and neoplasm.